logo-loader
LSE:DDDD

4D pharma plc

Receive alerts
Market:
LSE
Market Cap:
£108.79 m
Price
82.80 GBX
Change
15.00%
52 weeks high
131.00
52 weeks low
23.50

In brief

4D are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Deep dive We explore the investor case for growth companies

Snapshot

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease